Company intelligence / Profile preview

INEOS

London, United Kingdomineos.com ↗

Ownership: Private
Employees: ~24500
Development stage: Other

Overview

INEOS is the world’s largest producer of acetonitrile, a crucial raw material and solvent for the synthesis and purification of various pharmaceuticals including insulin and vaccines. Its new 'INVIREO' bio-based acetonitrile significantly reduces carbon footprint in pharma manufacturing. INEOS was also a major supplier of ultra-pure ethanol and isopropyl alcohol for sanitizer production during the COVID-19 pandemic. INEOS Hygienics, their consumer healthcare subsidiary launched in 2020, was sold to SKG Capital Partners in 2025.[1][2][3][4][5][7]

Industry: Chemicals & Materials

Beyond the preview

Go deeper on INEOS.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on INEOS.